Joshua Richter, MD, discusses long-term follow up data findings for multiple myeloma and their implications on front-line therapy options for patients.
ASH 2020 Post Conference Perspectives: Updates in Multiple Myeloma
An expert in the management of multiple myeloma discusses new data released from the GRIFFIN trial as well as real-world evidence regarding frontline autologous stem cell transplantation.
Joshua Richter, MD, provides an overview of new data from various trials presented at ASH 2020 regarding newly diagnosed patients with multiple myeloma.
An expert looks to the future directions in multiple myeloma and discusses upcoming advances in the field.
Advertisement
Advertisement
Trending on AJMC
1
Reduction in Food Allergies Found After Guideline-Directed Early Peanut Exposure
2
FDA Expands Semaglutide Label to Reduce Cardiovascular Risk in Adults With Type 2 Diabetes
3
Adding Radioligand Therapy Pluvicto to SOC Cuts Risk of Prostate Cancer Progression or Death 28%, but How Many Doses?
4
KEYNOTE-905 Paves the Way for Next Generation of MIBC Trials: Christof Vulsteke, MD, PhD
5
